<DOC>
	<DOCNO>NCT00364832</DOCNO>
	<brief_summary>This study determine appropriate dose frequency administration sc Mircera maintenance therapy dialysis patient chronic renal anemia previously receive sc epoetin alfa beta . The anticipated time study treatment 3-12 month target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Subcutaneous ( sc ) Mircera Dialysis Patients With Chronic Renal Anemia .</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>adult patient &gt; =18 year age ; chronic renal anemia ; dialysis ( hemodialysis peritoneal dialysis ) therapy least 3 month ; receive sc epoetin alfa beta least 3 month prior runin period . woman pregnant , breastfeed use unreliable birth control method ; use investigational drug within 30 day precede runin phase , runin study treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>